HOME › DRUGS › ASPARAGINASE
ACTIVE SUBSTANCE / INN

ASPARAGINASE

Brand name(s): Graspa, ELSPAR, Spectrila
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
BLA101063
Precursor Cell Lymphoblastic Leukemia-Lymphoma
ACTIVE SUBSTANCE
Asparaginase
REGULATORS
FDA · EMA
SPONSORS / MAH
ERYTECH Pharma S.A., MERCK, Medac Gesellschaft fuer klinische Spezialpraeparate mbH
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELSPARBLA101063MERCKPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SpectrilaMedac Gesellschaft fuer klinische Spezialpraeparate mbHAuthorised14/01/2016Precursor Cell Lymphoblastic Leukemia-Lymphoma
GraspaERYTECH Pharma S.A.Application withdrawn27/06/2018Precursor Cell Lymphoblastic Leukemia-Lymphoma

FULL INTELLIGENCE ON ASPARAGINASE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →